S-j Li
Yantai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
Journal: European review for medical and pharmacological sciences
Published: April 20, 2019
Effects of miR-132 on proliferation and apoptosis of pancreatic cancer cells via Hedgehog signaling pathway.
Journal: European review for medical and pharmacological sciences
Published: March 28, 2019
LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
Journal: European review for medical and pharmacological sciences
Published: February 20, 2019
miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer.
Journal: European review for medical and pharmacological sciences
Published: January 19, 2019
MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.
Journal: European review for medical and pharmacological sciences
Published: December 22, 2018
LncRNA LOC554202 promotes proliferation and migration of gastric cancer cells through regulating p21 and E-cadherin.
Journal: European review for medical and pharmacological sciences
Published: December 22, 2018
Association of the upregulation of LncRNA00673 with poor prognosis for colorectal cancer.
Journal: European review for medical and pharmacological sciences
Published: February 21, 2018
Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Journal: Genetics and molecular research : GMR
Published: December 15, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026